scholarly article | Q13442814 |
P356 | DOI | 10.1002/ANA.410360505 |
P698 | PubMed publication ID | 7979217 |
P50 | author | Andreas von Deimling | Q40381084 |
P2093 | author name string | Louis DN | |
Benedict WF | |||
Henson JW | |||
Fassbender F | |||
Yandell DW | |||
Xu HJ | |||
Correa KM | |||
Schnitker BL | |||
P433 | issue | 5 | |
P921 | main subject | retinoblastoma | Q500695 |
P304 | page(s) | 714-721 | |
P577 | publication date | 1994-11-01 | |
P1433 | published in | Annals of Neurology | Q564414 |
P1476 | title | The retinoblastoma gene is involved in malignant progression of astrocytomas | |
P478 | volume | 36 |
Q33891429 | A graphic method for identification of novel glioma related genes. |
Q52537791 | A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. |
Q40372189 | A tiger behind many doors: multiple genetic pathways to malignant glioma |
Q40167515 | Altered structure and deregulated expression of the tumor suppressor gene retinoblastoma (RB1) in human brain tumors |
Q48611673 | Analyses of human gliomas by restriction landmark genomic scanning |
Q48035681 | Analysis of chromosome abnormalities by comparative genomic hybridization in malignant peripheral primitive neuroectodermal tumor of the ovary |
Q48567039 | Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation |
Q33532647 | Automated network analysis identifies core pathways in glioblastoma |
Q48482815 | BCL-2 family protein expression in human malignant glioma: a clinical-pathological correlative study |
Q35753196 | CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations |
Q55473770 | Cell cycle regulators (p21, p53, pRb) in oligodendrocytic tumors: a study by novel tumor microarray technique. |
Q42021790 | Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks |
Q35634253 | Clinical stratification of glioblastoma based on alterations in retinoblastoma tumor suppressor protein (RB1) and association with the proneural subtype |
Q42118637 | Constitutively methylated CpG dinucleotides as mutation hot spots in the retinoblastoma gene (RB1). |
Q38302408 | CpG island methylation status and mutation analysis of the RB1 gene essential promoter region and protein-binding pocket domain in nervous system tumours |
Q24630927 | Curcumin and its derivatives: their application in neuropharmacology and neuroscience in the 21st century |
Q34283491 | Delivery of cell cycle genes to block astrocytoma growth |
Q40470907 | Delta24-hyCD adenovirus suppresses glioma growth in vivo by combining oncolysis and chemosensitization. |
Q26829873 | Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets |
Q37504261 | Detection of JC virus DNA sequence and expression of the viral oncoprotein, tumor antigen, in brain of immunocompetent patient with oligoastrocytoma |
Q35764748 | Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications |
Q35846538 | Dinaciclib, a Cyclin-Dependent Kinase Inhibitor Promotes Proteasomal Degradation of Mcl-1 and Enhances ABT-737-Mediated Cell Death in Malignant Human Glioma Cell Lines |
Q33253913 | Downregulation of RUNX3 and TES by hypermethylation in glioblastoma |
Q34787109 | Downregulation of TES by hypermethylation in glioblastoma reduces cell apoptosis and predicts poor clinical outcome |
Q35914897 | Emerging insights into the molecular and cellular basis of glioblastoma |
Q37003757 | Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study |
Q45613688 | Evaluation of miR-362 Expression in Astrocytoma of Human Brain Tumors |
Q48428399 | Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri |
Q35117832 | Genetic alterations of human brain tumors as molecular prognostic factors |
Q40543091 | Genetic alterations of the NRP/B gene are associated with human brain tumors |
Q37838362 | Genetic modeling of gliomas in mice: new tools to tackle old problems |
Q37348716 | Genetically engineered mouse models of brain cancer and the promise of preclinical testing |
Q48633313 | Genomic alterations in human glioma cell lines detected by restriction landmark genomic scanning |
Q37946264 | Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights |
Q37602543 | Glioblastoma Multiforme Oncogenomics and Signaling Pathways |
Q34366431 | Glioma models |
Q24297641 | HAUSP, a novel deubiquitinase for Rb - MDM2 the critical regulator |
Q36645878 | High-resolution genome-wide allelotype analysis identifies loss of chromosome 14q as a recurrent genetic alteration in astrocytic tumours |
Q55474476 | Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adults. |
Q40785730 | Identification of uncommon chromosomal aberrations in the neuroglioma cell line H4 by spectral karyotyping |
Q26862847 | In vivo models of primary brain tumors: pitfalls and perspectives |
Q35440540 | Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System. |
Q47193299 | Loss of heterozygosity on chromosomes 10q, 9p, 17p and 13q in malays with malignant glioma. |
Q53442919 | Loss of retinoblastoma gene function and heterozygosity at the RB locus in renal cortical neoplasms. |
Q33913068 | Low penetrance of retinoblastoma for p.V654L mutation of the RB1 gene |
Q48422991 | Malignant glioma: should chemotherapy be overthrown by experimental treatments? |
Q34002994 | Mesenchymal migration as a therapeutic target in glioblastoma |
Q38525862 | Missense mutation of the MET gene detected in human glioma |
Q41626535 | Molecular aspects of neuro-oncology |
Q27001295 | Molecular biology of gliomas: present and future challenges |
Q24678750 | Molecular genetic analysis of giant cell glioblastomas |
Q34478051 | Molecular genetics of pineal region neoplasms |
Q36226724 | Molecular mechanisms in gliomagenesis |
Q41687849 | Molecular neuropathology of astrocytic brain tumors |
Q40961534 | Molecular pathways in the formation of gliomas. |
Q37858944 | Molecular subclassification of diffuse gliomas: seeing order in the chaos |
Q41903586 | Multiple deleted regions on the long arm of chromosome 6 in astrocytic tumours |
Q35795458 | NF2 gene analysis distinguishes hemangiopericytoma from meningioma. |
Q30426593 | P16 deletion and mutation analysis in human brain tumors |
Q37640890 | PCNA and Ki-67 labelling indices in pre-irradiated and post-irradiated astrocytomas: a comparative immunohistochemical analysis for evaluation of proliferative activity |
Q55474611 | Promoter hypermethylation of the RB1 gene in glioblastomas. |
Q48657987 | Retinoblastoma protein expression and MIB-1 correlate with survival of patients with malignant astrocytoma |
Q48262753 | Simultaneous alterations of retinoblastoma and p53 protein expression in astrocytic tumors |
Q37736255 | Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma |
Q30998003 | Techniques to assess the proliferative potential of brain tumors |
Q30357109 | The N Terminus of the Retinoblastoma Protein Inhibits DNA Replication via a Bipartite Mechanism Disrupted in Partially Penetrant Retinoblastomas. |
Q24657924 | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo |
Q37220909 | The molecular genetics of astrocytomas: current understanding and future applications |
Q28118814 | The neural progenitor-restricted isoform of the MARK4 gene in 19q13.2 is upregulated in human gliomas and overexpressed in a subset of glioblastoma cell lines |
Q33921072 | The pathobiology of glioma tumors |
Q41731369 | The role of transforming growth factor beta in glioma progression |
Q55478756 | Transforming growth factor beta as a potential tumor progression factor among hyperdiploid glioblastoma cultures: evidence for the role of platelet-derived growth factor. |
Q32034495 | Trilateral retinoblastoma: insights into histogenesis and management |
Q34278098 | Tumor suppression by a severely truncated species of retinoblastoma protein |
Q30661179 | Voting-based cancer module identification by combining topological and data-driven properties |
Search more.